Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The launch coincides with IBS Awareness Month in April
The innovation is particularly suited for bone and cartilage repair
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The company reported net revenue of SEK 13.5 million for the full year 2025
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Subscribe To Our Newsletter & Stay Updated
